🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of the WARIFA App and Its Impact on Healthy Lifestyle

RecruitingNAAges 18 Years - anyAllInstituto Universitario de Investigaciones Bioméd…
NCT06918444 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this study is to assess the effect of the WARIFA app on the adoption of healthy lifestyle behaviours related to Non-communicable diseases (NCDs), as well as in the management of Type 1 Diabetes (T1D). This is done using user-generated data analysis, artificial intelligence (AI) and risk estimation to provide personalised recommendations on lifestyle-related behaviours through a mobile app. * Primary objective: the objective of this study is to assess the impact of using the WARIFA app on a series of outcomes, related to the promotion of healthy lifestyles and prevention of NCDs, as well as on the management of T1D. * Secondary objectives: to assess the feasibility of implementation of a complex health app (WARIFA), and to explore which outcomes are more relevant in this context for users. The study will evaluate the app in two different populations: * Population 1: Citizen

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Common for both population groups: * Adults over 18 years of age. * Owners of a smartphone operating with Android and with internet access. * Group 1: General population: * Healthy or diagnosed with no more than one NCD (CVD, any type of cancer, T2D or chronic respiratory disease). * Group 2: T1D: * Treatment with multiple subcutaneous insulin injections or an insulin pump. * Users of a continuous glucose monitor. Exclusion Criteria: * Common for both groups: * Pregnancy. * Mobile device which is incompatible with the WARIFA app (E.g. Apple devices). * Unable to understand any of the app languages (Spanish, English, Norwegian or Romanian). * Any reason which precludes follow-up, based on the researcher's criteria. * Group 1: General population * People with two or more NCDs.
💊

What it tests

  • WARIFA app with AI
  • WARIFA app without AI
📍

Where

1 site
Instituto Universitario De Investigaciones Biomédicas y Sanitarias (IUIBS)
Las Palmas de Gran Canaria, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy